What is a stock summary page? Click here for an overview.
Business Description
icad Inc
NAICS : 339112
SIC : 3845
ISIN : US44934S2068
Description
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 47.53 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.62 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -18.2 | |||||
| 3-Year EBITDA Growth Rate | 24.3 | |||||
| 3-Year EPS without NRI Growth Rate | 22.5 | |||||
| 3-Year FCF Growth Rate | 25.1 | |||||
| 3-Year Book Growth Rate | -16.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 68.88 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.74 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.97 | |||||
| 9-Day RSI | 77.44 | |||||
| 14-Day RSI | 71.41 | |||||
| 3-1 Month Momentum % | -6.2 | |||||
| 6-1 Month Momentum % | 15.82 | |||||
| 12-1 Month Momentum % | 53.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | |||||
| Quick Ratio | 3.4 | |||||
| Cash Ratio | 2.28 | |||||
| Days Inventory | 93.62 | |||||
| Days Sales Outstanding | 115.08 | |||||
| Days Payable | 124.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | 1.54 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.83 | |||||
| Operating Margin % | -31.97 | |||||
| Net Margin % | -28.64 | |||||
| FCF Margin % | -22.77 | |||||
| ROE % | -18.13 | |||||
| ROA % | -14.37 | |||||
| ROIC % | -38.78 | |||||
| 3-Year ROIIC % | -165.97 | |||||
| ROC (Joel Greenblatt) % | -145.56 | |||||
| ROCE % | -17.01 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.41 | |||||
| PB Ratio | 3.01 | |||||
| Price-to-Tangible-Book | 4.26 | |||||
| EV-to-EBIT | -13.24 | |||||
| EV-to-EBITDA | -14.93 | |||||
| EV-to-Revenue | 3.72 | |||||
| EV-to-Forward-Revenue | 0.6 | |||||
| EV-to-FCF | -16.33 | |||||
| Price-to-GF-Value | 1.91 | |||||
| Price-to-Median-PS-Value | 1.74 | |||||
| Price-to-Net-Current-Asset-Value | 4.9 | |||||
| Price-to-Net-Cash | 10.25 | |||||
| Earnings Yield (Greenblatt) % | -7.55 | |||||
| FCF Yield % | -4.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICAD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
icad Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 19.608 | ||
| EPS (TTM) ($) | -0.22 | ||
| Beta | 1.62 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.13 | ||
| Volatility % | 89.53 | ||
| 14-Day RSI | 71.41 | ||
| 14-Day ATR ($) | 0.232633 | ||
| 20-Day SMA ($) | 2.313 | ||
| 12-1 Month Momentum % | 53.38 | ||
| 52-Week Range ($) | 1.18 - 3.78 | ||
| Shares Outstanding (Mil) | 27.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
icad Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
icad Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
icad Inc Frequently Asked Questions
What is icad Inc(ICAD)'s stock price today?
The current price of ICAD is $3.28. The 52 week high of ICAD is $3.78 and 52 week low is $1.18.
When is next earnings date of icad Inc(ICAD)?
The next earnings date of icad Inc(ICAD) is 2025-05-15 Est..
Does icad Inc(ICAD) pay dividends? If so, how much?
icad Inc(ICAD) does not pay dividend.
Guru Commentaries on NAS:ICAD
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers